Scientists have designed a slimmed-down CRISPR protein, enEbCas12a, that still packs a punch in precision editing. Its small size means it can hitch a ride in a harmless virus, delivering edits ...

SCD gene therapy approaches using CRISPR, gene therapy, and base editing show different stem cell outcomes in a mouse study.

enEbCas12a enables all-in-one AAV delivery system. Credit: Chen Peng (CC-BY 4.0, creativecommons.org/licenses/by/4.0/) Researchers have developed a novel version of a ...

Three patients are in “safe, deep remission” after receiving a CRISPR-Cas9-modified cell therapy for autoimmune disease treatment, according to a new published study in Cell. Unlike traditional ...

The furore that accompanied the news that Chinese scientist He Jiankui had carried out gene-editing on twin girls threatens to overshadow the strides forward being made by biopharma companies ...

Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver ...

Newark, May 07, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 3.16 billion in 2023 global CRISPR and Cas Gene market will reach USD 15.60 billion by 2033. Cell and gene therapy ...